Diagnosing Diabetic Retinopathy With Artificial Intelligence: What Information Should Be Included to Ensure Ethical Informed Consent?

Purpose: The method of diagnosing diabetic retinopathy (DR) through artificial intelligence (AI)-based systems has been commercially available since 2018. This introduces new ethical challenges with regard to obtaining informed consent from patients. The purpose of this work is to develop a checklis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ursin, Frank, Timmermann, Cristian, Orzechowski, Marcin, Steger, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333706/
https://www.ncbi.nlm.nih.gov/pubmed/34368192
http://dx.doi.org/10.3389/fmed.2021.695217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333706/
https://www.ncbi.nlm.nih.gov/pubmed/34368192
http://dx.doi.org/10.3389/fmed.2021.695217

Ejemplares similares